← Back to Cerebrolysin

VS Peps · Certificate № JN-260528-3348

Certificate of Analysis

Compound identity

CBR

Cerebrolysin

Neurotrophic peptide complex · 215mg solution

Batch identifiers

Batch IDJN-260528-3348
Lab referenceLR-46916
Test date2026-05-28
Format215mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.4%

Area under the target peak as a percentage of total area.

Batch · 2026-05-28Janoshik Analytical · HPLC
99.4%CBR2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameCerebrolysin
Editorial codeCBR
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

Non-peptide structure
3-letter notation

Modifications

  • 01Porcine brain peptide preparation
  • 02Low-molecular-weight neurotrophic fraction (≤10 kDa)

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Pre-formulated sterile solution. Refrigerate at 2–8°C. Do not freeze. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-28

Document control

Certificate № JN-260528-3348Issued 2026-05-28Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.